Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fingolimod vs Interferon Beta-1b for Visual Recovery in Acute Optic Neuritis
NCT01647880Phase 3Terminated
- Sponsor
- Charité – Universitätsmedizin Berlin
- Start
- Jul 2013
- Primary completion
- Apr 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of fingolimod in optic neuritis (ON), sponsored by Charité – Universitätsmedizin Berlin. Started Jul 2013; status: terminated.
02
Drugs
fingolimod
03
Conditions
optic neuritis (ON)
Beyond the preview
Go deeper on NCT01647880.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01647880.